Recorded Webinar from Nov 9, 2017


Assessing the immunogenicity of biopharmaceuticals


Immunogenicity of therapeutic biopharmaceuticals can impact both the efficacy and the safety of the product. Assessment of anti-drug antibodies (ADAs) as well as neutralizing antibodies (NAbs) is a fundamental part of immunogenicity testing. 


By listening to this webinar, you will learn:

  • how the Gyrolab™ platform automates drug-tolerant ADA immunoassays in a time-efficient way using small volumes of patient samples and reagents
  • how iLite® Assay Ready reporter gene cell lines are designed to overcome limitations of conventional cell-based assays in the assessment of neutralizing antibodies



Cecilia Bill-webb.pngCecilia Bill,
Application Scientist, Gyros Protein Technologies AB






Frida Pauly.pngFrida Pauly,
Manager Biopharma Solutions, Euro Diagnostica AB






If you have problems to view the webinar please contact

Fill in form to access the webinar